NR3C2 and Hyperkalemia: While mineralocorticoid receptor antagonists (MRAs) have mild diuretic effects and do improve prognosis in HF with reduced ejection fraction (EF) [38], hyperkalemia and WRF are common side effects of these drugs as well [39].